Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Interim Management Statement

13 Jul 2010 10:36

RNS Number : 2561P
Maven Income & Growth VCT PLC
13 July 2010
 



 

Maven Income and Growth VCT PLC (the Company)

 

Interim Management Statement - quarter ended 31 May 2010

 

This Interim Management Statement, for the quarter ended 31 May 2010 is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 June 2010 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

·; Net Asset Value (NAV)* of 61.7p per share at 31 May 2010 compared to 62.3p per share at 28 February 2010; and

·; Final dividend of 3.0p per share in respect of the year ended 28 February 2010, approved by Shareholders at the Annual General Meeting for payment on 23 July 2010.

 

\* The NAV is unaudited and reflects the closing bid price of quoted securities at 31 May 2010. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 28 February 2010, adjusted for subsequent events where appropriate.

 

2.

Investments and disposals

 

During the quarter ended 31 May 2010, investments totalling £878,000 were made in five unlisted companies.

 

During the same period, a combination of partial and complete disposals of one unlisted investment and three AIM quoted investments generated aggregate proceeds of £842,000 against cost of £681,000.

 

3.

Recent developments

 

Between 1 June 2010 and the date of this statement, a total of £456,000 was invested in two unlisted companies. During the same post quarter-end period, £76,000 of loan stock was redeemed at par by an unlisted company, deferred consideration of £15,000 was received from the previous disposal of an unlisted investment; disposals of two AIM quoted investments generated aggregate proceeds of £23,000 against cost of £45,000; and £1,200,000 of UK treasury stock was redeemed at par.

 

With effect from the close of the Annual General Meeting held on 8 July 2010, and in accordance with the statement made in the Annual Report for the year ended 28 February 2010, John Pocock has replaced Fiona Wollocombe as Chairman of the Company; Mrs Wollocombe will remain a Director until the conclusion of the year ending 28 February 2011.

 

Other than described above and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 March to 31 May 2010, or in the period from 1 June 2010 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

13 July 2010

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUAWMUPUUBW
Date   Source Headline
24th Aug 20153:33 pmRNSStatement re Dividend Investment Scheme
17th Jul 20154:33 pmRNSIssue of Equity
17th Jul 201510:42 amRNSNet Asset Value(s)
9th Jul 20154:23 pmRNSNet Asset Value(s)
9th Jul 20154:16 pmRNSDirectorate Change
9th Jul 20154:11 pmRNSResult of AGM
5th Jun 20154:35 pmRNSAnnual Financial Report
6th May 20152:26 pmRNSStatement re NAV & Proposed Dividend Declaration
13th Apr 20153:08 pmRNSIssue of Equity
27th Mar 20154:46 pmRNSDirector/PDMR Shareholding
27th Mar 20154:45 pmRNSDirector/PDMR Shareholding
27th Mar 20154:45 pmRNSDirector/PDMR Shareholding
20th Mar 20154:52 pmRNSIssue of Equity
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201510:41 amRNSDirector/PDMR Shareholding
26th Feb 201510:38 amRNSDirector/PDMR Shareholding
26th Feb 201510:38 amRNSDirector/PDMR Shareholding
20th Feb 20152:44 pmRNSIssue of Equity
5th Feb 20155:00 pmRNSStatement re Offers for Subscription
3rd Feb 20153:07 pmRNSStatement re Offers for Subscription
30th Jan 20154:53 pmRNSStatement re Offers for Subscription
28th Jan 20152:21 pmRNSNet Asset Value(s)
21st Jan 20153:47 pmRNSStatement re Offers and Related Party Transactions
20th Jan 20159:48 amRNSStatement re Offers for Subscription
7th Jan 20152:11 pmRNSStatement re Offers for Subscription
28th Nov 20144:22 pmRNSTransaction in Own Shares
28th Oct 20147:00 amRNSHalf Yearly Report
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
10th Oct 20149:57 amRNSNet Asset Value(s)
3rd Oct 20144:20 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
5th Aug 20144:05 pmRNSTransaction in Own Shares
4th Aug 20144:28 pmRNSTransaction in Own Shares
31st Jul 20143:51 pmRNSTransaction in Own Shares
11th Jul 20142:46 pmRNSInterim Management Statement
10th Jul 20142:06 pmRNSResult of AGM
4th Jul 20144:28 pmRNSReplacement re Issue of Equity
2nd Jul 20149:45 amRNSIssue of Equity
6th Jun 20144:48 pmRNSAnnual Financial Report
28th May 20145:07 pmRNSOffer for Subscription Update
21st May 20149:55 amRNSNet Asset Value(s)
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:43 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 20144:11 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:27 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
17th Feb 201412:31 pmRNSDirector/PDMR Shareholding
10th Feb 20146:02 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:16 pmRNSIssue of Equity
23rd Jan 20142:53 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.